Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$891M |
| 2 |
Union Pacific
UNP
|
+$622M |
| 3 |
Salesforce
CRM
|
+$418M |
| 4 |
Edwards Lifesciences
EW
|
+$405M |
| 5 |
lululemon athletica
LULU
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$680M |
| 2 |
Texas Instruments
TXN
|
+$585M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$558M |
| 5 |
Parker-Hannifin
PH
|
+$556M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.09% |
| 2 | Healthcare | 17.49% |
| 3 | Consumer Discretionary | 17.05% |
| 4 | Financials | 12.69% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Natera
NTRA
$36.5B
| $51.7M | 0.06% |
3,706,873
+65,025
| +2% | +$1.19M |
|
|
MRTX
202
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $51.6M | 0.06% |
1,216,464
+217,960
| +22% | +$8.69M |
|
203
Monster Beverage
MNST
$95.3B
| $51.4M | 0.06% |
2,087,212
-5,463,554
| -72% | -$148M |
|
204
Texas Roadhouse
TXRH
$13.7B
| $51.1M | 0.06% |
856,735
+151,919
| +22% | +$9.75M |
|
205
Elevance Health
ELV
$81.9B
| $50.2M | 0.06% |
191,133
+1,994
| +1% | +$548K |
|
|
GWPH
206
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $50.2M | 0.06% |
515,281
+145,227
| +39% | +$19.1M |
|
207
Church & Dwight Co
CHD
$23.6B
| $50.1M | 0.06% |
762,017
-199,863
| -21% | -$12.7M |
|
|
208
Caterpillar
CAT
$363B
| $49.7M | 0.06% |
390,849
-5,226,861
| -93% | -$680M |
|
209
argenx
ARGX
$55.1B
| $48.7M | 0.05% |
506,971
-4,250
| -0.8% | -$378K |
|
210
CoStar Group
CSGP
$12.2B
| $48.3M | 0.05% |
1,432,460
+94,120
| +7% | +$3.44M |
|
|
TRHC
211
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $48.2M | 0.05% |
755,474
-928
| -0.1% | -$65.7K |
|
212
Clearway Energy Class C
CWEN
$4.79B
| $48M | 0.05% |
2,780,860
-251,078
| -8% | -$4.68M |
|
213
American Water Works
AWK
$26.9B
| $47.5M | 0.05% |
523,236
| – | – |
|
214
Avient
AVNT
$3.28B
| $47.3M | 0.05% |
1,654,008
+5,699
| +0.3% | +$191K |
|
215
Pebblebrook Hotel Trust
PEB
$2.18B
| $47.3M | 0.05% |
1,669,746
-43,033
| -3% | -$1.43M |
|
216
ProQR Therapeutics
PRQR
$251M
| $47.3M | 0.05% |
2,995,305
-2,789
| -0.1% | -$51.2K |
|
|
AAMI
217
Acadian Asset Management
AAMI
$2.92B
| $46.7M | 0.05% |
4,373,577
+62,233
| +1% | +$748K |
|
218
Guidewire Software
GWRE
$14B
| $46.5M | 0.05% |
580,131
-26,707
| -4% | -$2.33M |
|
219
Trinity Industries
TRN
$2.87B
| $46.3M | 0.05% |
2,250,877
-101,440
| -4% | -$2.34M |
|
220
Korn Ferry
KFY
$4.33B
| $46.1M | 0.05% |
1,166,508
+70,210
| +6% | +$3.16M |
|
221
Xcel Energy
XEL
$49.1B
| $45.8M | 0.05% |
929,809
-391,579
| -30% | -$19.6M |
|
222
Agnico Eagle Mines
AEM
$72.7B
| $45.6M | 0.05% |
1,128,001
-13,262
| -1% | -$489K |
|
223
Moody's
MCO
$84.1B
| $45.5M | 0.05% |
324,841
-47,484
| -13% | -$7.16M |
|
224
Cheniere Energy
CQP
$30.8B
| $45.4M | 0.05% |
1,258,716
-58,967
| -4% | -$2.15M |
|
225
IMAX
IMAX
$2.63B
| $45.2M | 0.05% |
2,402,161
+33,257
| +1% | +$679K |
|
Similar funds
Jennison Associates's Q4 2018 Portfolio in Review
As of Q4 2018, Jennison Associates held 753 positions worth $89.4B, down 18% from $109B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q4 2018 filing shows 95 new, 255 increased, 283 reduced and 113 closed positions. Its largest new stake was lululemon athletica: 2,588,881 shares worth $315M. The largest sale was Caterpillar, an estimated $680M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jennison Associates's largest Q4 2018 buy was lululemon athletica: 2,588,881 shares worth $315M.
- Jennison Associates added most to Merck in Q4 2018, an estimated $891M increase.
- Jennison Associates's biggest Q4 2018 reduction was Caterpillar, cutting an estimated $680M.
- Jennison Associates fully exited Tiffany & Co. in Q4 2018, selling an estimated $151M.
- Jennison Associates's ten largest holdings make up 30% of its $89.4B portfolio in Q4 2018.
- Jennison Associates opened 95 new positions and closed 113 in Q4 2018.
- Jennison Associates's portfolio value fell 18% quarter-over-quarter to $89.4B.
Based on Jennison Associates's 13F filing for Q4 2018, filed 6 Feb 2019.